Subsequently, we examined the relationship between hmmyCAF infiltration and established immunotherapy response predictors: tumor mutation burden (TMB), microsatellite instability (MSI), and immune checkpoint expression profiles (PD‐1/PD‐L1, CTLA‐4, TIM‐3). This evidence concerns the gene HAVCR2 and neoplasm.